SCHEMBL375294

SCHEMBL375294

CC1CC(NCc2ccc(F)c(Br)c2)CC(C)O1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 0.37
KDM4E B2RXH2 3/20 0.37
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
PDE1B Q01064 1/20 0.35
DYRK1A Q13627 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
CARM1 Q86X55 2/20 0.32
PRMT6 Q96LA8 2/20 0.32
POLB P06746 1/20 0.32
FAAH O00519 1/20 0.32
SLC6A2 P23975 1/20 0.32
HRH2 P25021 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL999995 0.78 POLB (0.54) KDM4EALDH1A1TSHRPOLB
SCHEMBL15104570 0.78 POLB (0.50) KDM1AKDM4EALDH1A1TSHRPOLB
SCHEMBL374926 0.77 PARP1 (0.43) KDM1AKDM4EDYRK1ACLK4CYP2D6
SCHEMBL1000678 0.77 HRH3 (0.56) KDM4EALDH1A1TSHRPOLB
SCHEMBL374844 0.74 KDM4E (0.51) KDM1AKDM4EDYRK1ACLK4ALDH1A1
SCHEMBL375612 0.73 HTT (0.62) KDM4EDYRK1ACLK4CYP2D6CYP2C19
SCHEMBL31682518 0.72 GRIN2B (0.50) KDM1AMAOACARM1PRMT6HRH2
SCHEMBL1363941 0.70 CYP1A2 (0.44) KDM4EDYRK1ACLK4CYP1A2CYP2D6
SCHEMBL30163579 0.69 KCNH2 (0.46) KDM4ECYP1A2POLB
SCHEMBL30163569 0.69 KCNH2 (0.46) KDM4ECYP1A2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623898-B2 Glycine transporter inhibiting substances TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-01-07 US disclosed
EP-2409976-A1 GLYCINE TRANSPORTER INHIBITOR Taisho Pharmaceutical Co., Ltd. (JP) 2012-01-25 EP disclosed
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES SLC18A2, SLC1A2, SLC6A1 KDM1A 4445/4885KDM4E 4384/4885MAOA 325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.